Defense World
16 Aug 2026, 08:11 UTC · 1w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Major investment banks including Goldman Sachs, Sanford C. Bernstein, and Wells Fargo have issued Buy/Outperform ratings with price targets ranging from $200 to $221. — Strong consensus and high price targets from top-tier analysts typically drive institutional buying and upward price pressure.
+0.60Corporate insiders sold 376,612 shares valued at approximately $59.5 million over the last three months. — Significant insider selling can be perceived as a lack of confidence in near-term growth, though some sales were via 10b5-1 plans.
-0.40Institutional ownership of Neurocrine Biosciences is very high at 92.59%. — High institutional density suggests strong professional validation but can also lead to volatility if a major fund decides to exit.
+0.20Continue reading
6 related stories
Search tags
ABN AMRO Bank N.V. established a new position in the company during Q2 with a purchase of 14,787 shares. — The entry of a new institutional investor is a positive signal, though the position size relative to market cap is immaterial.
+0.10Which stocks this story touches
Strong positive analyst ratings and increased institutional holdings outweigh the impact of scheduled insider selling.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
21h ago
